These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12583308)

  • 1. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():13-8. PubMed ID: 12583308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy.
    Hussein MM; Mooij JM; Roujouleh H
    Clin Nephrol; 1993 Sep; 40(3):160-3. PubMed ID: 8403571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J; Galesić K; Dancuo I; Vergles D
    Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
    Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():6-12. PubMed ID: 12583307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
    Boumpas DT; Sidiropoulos P; Bertsias G
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A; Hotta O; Yusa N; Taguma Y
    Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
    Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
    Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].
    Anić B; Crkvencić N; Mayer M; Bosnić D; Sentić M; Markeljević J; Cikes N
    Lijec Vjesn; 1999; 121(9-10):283-8. PubMed ID: 19658369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
    Ianushkevich TN; Klepikov PV
    Ter Arkh; 1990; 62(6):50-3. PubMed ID: 2218927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
    Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
    Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N; Dimitrova V
    Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.